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Purpose: Mutations in tetraspanin 12 (TSPAN12) have recently been identified as a cause of autosomal dominant familial
exudative vitreoretinopathy (FEVR). The purpose of this study was to detect TSPAN12 mutations in Chinese patients with
FEVR and to describe the associated phenotypes.
Methods: Sanger sequencing was used to analyze the seven coding exons and their adjacent regions of TSPAN12 in 49
unrelated FEVR patients. Clinical phenotypes of the patients with TSPAN12 mutations were documented.
Results: Three novel heterozygous mutations in TSPAN12 were identified in three patients from unrelated families: c.
146C>T (p.Thr49Met), c.313T>C (p.Cys105Arg), and c.601delC (p.Leu201PhefsX14). All three mutations involved
highly conserved residues and were not present in 180 normal individuals. Ocular phenotypes included retinal folds,
inferotemporal dragging of the optic disc and macula, increased vessels in the equatorial region, and a peripheral avascular
zone. A father and his daughter had the same mutation but the father only had mild peripheral fundus changes while his
daughter had obvious dragged disc and macular ectopia.
Conclusions: Our results suggest that TSPAN12 mutations are responsible for FEVR. Similar to patients with mutations
in NDP, LRP5, or FZD4, the phenotypes associated with TSPAN12 mutations showed great variations between different
individuals within a family and between the two eyes in individual patients.
Familial  exudative  vitreoretinopathy  (FEVR,  OMIM
133780) is a hereditary vitreoretinal disorder characterized by
developmental  anomalies  of  the  retinal  vessels  [1].  The
primary anomaly is a premature arrest of the vascularization
in  the  peripheral  retina,  which  may  lead  to  retinal
neovascularization,  vitreoretinal  traction,  exudates,
fibrovascular masses, vitreous hemorrhages, retinal folds, and
tractional  retinal  detachment.  FEVR  exhibits  strikingly
variable phenotypes among patients, even for patients from
the same family or between the two eyes of an individual
patient. The most severe form results in complete blindness,
whereas  minimally  affected  individuals  can  be  totally
asymptomatic, in which nonperfusion or avascular zones in
the peripheral retina may only be identified by fluorescein
angiography [2].
FEVR can be inherited as an autosomal dominant (OMIM
133780) [1,3-5], autosomal recessive (OMIM 601813) [6,7],
or X-linked (OMIM 305390) [8,9] trait, and the autosomal
dominant form is the most common [10,11]. Mutations in
NDP (OMIM 300658) [8,12], FZD4 (OMIM 604579) [13],
and LRP5 (OMIM 603506) [14,15] have been reported to be
responsible for FEVR. The proteins encoded by these genes
have all been shown to participate in the Wnt/Norrin signaling
pathway [16-19]. Mutations in NDP,FZD4, and LRP5 account
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for approximately half of all FEVR cases, which indicates that
additional causative genes remain to be identified [20-26].
Recently,  heterozygous  mutations  in  tetraspanin  12
(TSPAN12; OMIM 613138), which is a component of the
Norrin-FZD4-LRP5 signaling complex [16,19], have been
found to be responsible for autosomal dominant FEVR [27,
28]. However, the frequency of TSPAN12 mutations and their
associated phenotypes need further study.
In this study, Sanger sequencing was used to analyze the
coding  and  adjacent  intronic  regions  of  TSPAN12  in  49
unrelated Chinese FEVR patients. Three novel heterozygous
mutations were identified, and the associated phenotypes were
described.
METHODS
Patients: Probands with FEVR from 49 unrelated families
were  collected  at  the  Pediatric  and  Genetic  Eye  Clinic,
Zhongshan Ophthalmic Center, Guangzhou, China. Of the 49,
34  were  sporadic  and  15  had  a  family  history  of  FEVR.
Clinical diagnosis of FEVR was based on the presence of at
least one of the following clinical findings that suggested
primary retinal vascular developmental defects as previously
described [21,23,24]: a peripheral retinal avascular zone with
or without fibrous proliferation, peripheral neovascularization
showing  increased  branching  or  a  brushlike  border,  a
peripheral fibrovascular mass, temporal dragging of the optic
disc  and/or  macula,  straightening  of  the  temporal  retinal
vessels, falciform retinal folds, tractional retinal detachment
with or without retinal exudates or vitreous hemorrhages, or
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1128total retinal detachment with fibrotic mass behind the lens.
Retinal  fluorescein  angiography  was  performed  in  some
suspicious cases to confirm the diagnosis of FEVR. Patients
with a possible diagnosis of retinopathy of prematurity were
excluded from the study. This study was approved by the
Internal Review Board (IRB) of the Zhongshan Ophthalmic
Center. It complied with the guidelines of the Declaration of
Helsinki and the Guidance of Sample Collection of Human
Genetic Diseases (863-Plan) of the Ministry of Public Health
of  China.  Informed  consent  was  obtained  from  the
participating  individuals  or  their  guardians  before  the
collection of clinical data and genomic samples.
Detection  of  TSPAN12  mutations:  Genomic  DNA  was
retrieved  from  our  genomic  DNA  repository,  which  was
established for the genetic study of hereditary eye disease.
Seven pairs of primers (Table 1) were designed to amplify all
the  coding  exons  and  the  adjacent  intronic  sequences  of
TSPAN12 (reference sequences from NCBI: NC_000007.13
for gDNA, NM_012338.3 for mRNA, and NP_036470.1 for
protein). Touchdown PCR was performed, with the annealing
temperature decreased by 2 °C after the first 5 cycles and the
second 5 cycles, and then down to the optimal annealing
temperature (listed in Table 1) for the remaining 25 cycles.
The sequences of the amplicons were determined with an ABI
BigDye Terminator Cycle Sequencing Kit, v3.1, using an ABI
3100 Genetic Analyzer (Applied Biosystems, Foster City,
CA).  Sequences  from  patients  and  TSPAN12  consensus
sequences  from  the  NCBI  human  genome  database
(NC_000007.13)  were  compared  using  the  SeqManII
program of the Lasergene package (DNAstar, Madison, WI).
Each  variation  was  initially  confirmed  by  bidirectional
sequencing and then evaluated in 180 normal individuals (360
chromosomes). The description of the mutations was based
on the recommendations of the Human Genomic Variation
TABLE 1. PRIMERS USED FOR PCR AMPLIFICATION AND SEQUENCING OF TSPAN12.
Exon Forward primer(5′-3′) Reverve primer(5′-3′) Amplicon size
(bp)
Annealing tempeture
(°C)
2 GCTGTGGGAAGCGTGAT TTAGCCATGCCCTTTGG 281 58
3 TTCAAGATGCAGCAAATGGTAAT GCTATGGGCAGGAAAAACTT 329 58
4 ATGTCTTGGGTGCATTT AAGCGTCCCTTCTTACA 321 56
5 AGGGCTCACTGAGATGA TCTTGGGCAGTTCTTTC 382 55
6 TTAGAAGACATTCCGAGTA AATTGCACCAGAGGTTA 360 55
7 TCCTTTACTACATTTCTATC TAGCTTTCTTCTGCTTC 462 52
8 ACAGATTGTTTGCTTTC AGGTGTTATTTTATGGC 505 52
Figure 1. Mutations identified in TSPAN12. A: The patient in the family had c.146C>T mutation. B; The patient in the family had c.313T>C
mutation. C:  The affected father and daughter had c.601delC mutation.  The columns from left to right  display the  pedigree and the
sequence chromatograms for these patients and the normal controls.
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1129Society. The effect of a missense mutation on the encoded
protein was predicted by the PolyPhen-2 online tool [29].
RESULTS
After  sequencing  the  coding  and  adjacent  regions  of
TSPAN12  in  49  unrelated  FEVR  patients,  three  novel
heterozygous mutations were detected in three patients: c.
146C>T, c.313T>C, and c.601delC (Figure 1). These three
mutations were not present in the 180 normal individuals.
The c.146C>T mutation in exon 3 changed the encoded
residue from a hydrophilic threonine to a sulfur-containing
hydrophobic methionine at codon 49 (p.Thr49Met), which
involves a highly evolutionarily conserved residue (Figure 2).
This mutation was predicted to probably be damaging by
PolyPhen-2. The c.313T>C mutation in exon 5 changed the
encoded  residue  from  a  thiol-containing  cysteine  to  a
positively  charged  basic  arginine  at  codon  105
(p.Cys105Arg), which is highly conserved (Figure 2). This
mutation  was  also  predicted  to  probably  be  damaging  by
PolyPhen-2.  The  c.601delC  mutation  in  exon  7  not  only
changed the residue at codon 201, but also created a frame
shift  with  14  additional  new  residues  before  a  premature
termination at codon 215 (p.Leu201PhefsX14). This mutation
also involved an evolutionarily conserved region.
All  patients  with  the  three  novel  mutations  showed
typical  signs  of  FEVR.  The  patient  with  the  c.146C>T
mutation in Family A was a six-year-old boy with strabismus.
Falciform retinal folds in the left fundus were seen upon
ophthalmoscopic observation. His parents were recorded to
have normal visual acuity, but they were not available for
additional  examination.  The  patient  with  the  c.313T>C
mutation  in  Family  B  was  a  nine-year-old  boy  with  a
complaint of poor visual acuity in the left eye. He had normal
visual  acuity  in  the  right  eye  but  only  recognized  hand
movement with the left eye. His right fundus was normal, but
his  left  fundus  showed  the  following  changes:  macular
degeneration  with  pigment  proliferation,  mild  temporal
dragging  of  the  optic  disc,  pigmentary  deposits  on  the
midperipheral retina, increased ramification of the peripheral
retinal vessels, and an avascular zone on the peripheral retina
(Figure 3). His parents were recorded to have normal visual
acuity, but they were not available for additional examination.
The  heterozygous  c.601delC  mutation  in  Family  C  was
detected in the proband and in her asymptomatic father. The
proband  was  a  three-year-old  girl  with  a  complaint  of
esotropia. Fundus examination showed typical inferotemporal
dragging of the optic disc and macula in both eyes (Figure 4).
Her  mother  had  normal  fundi  (Figure  5A,B);  but  her
asymptomatic father had typical fundus changes, although he
had  normal  visual  acuity  of  1.0  in  both  eyes.  The
asymptomatic  father  had  straightening  and  increased
branching of his peripheral retinal vessels (Figure 5C-F) but
showed normal macula on optical coherence tomography scan
(Figure 5G,H).
DISCUSSION
In this study, three novel TSPAN12 mutations were detected
in  three  patients  with  FEVR,  but  not  in  180  normal
individuals. Segregation analysis in one family indicated a
dominant role for the mutation. The two missense mutations
occurred in evolutionarily conserved regions of TSPAN12 and
were  predicted  to  be  pathogenic.  These  lines  of  evidence
Figure 2. Protein alignment of 12 (TSPAN12) orthologs demonstrates conservation in the regions with mutations. The 12 orthologs are from
the following 12 species: Homo sapiens (NP_036470), Pan troglodytes (XP_001142304), Mus musculus (NP_766595), Rattus norvegicus
(Q569A2),  Bos  taurus  (NP_001039977),  Equus  caballus  (XP_001502093),  Canis  familiaris  (XP_855095),  Monodelphis  domestica
(XP_001364876), Gallus gallus (NP_001007850), Taeniopygia guttata (XP_002192381), Ornithorhynchus anatinus (XP_001516347), and
Danio rerio (NP_957446). The regions with the two missense mutations are highly conserved. T49M stands for p.Thr49Met and C105R stands
for p.Cys105Arg.
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cause of FEVR in these patients.
Previously, nine TSPAN12 mutations in patients with
FEVR were reported. All 12 mutations, including the three
reported in this study, are distributed throughout all coding
exons, except for exon 2 (Figure 6). These 12 mutations can
be  classified  into  missense  mutations  (six),  nonsense
mutations (two), insertion or deletion mutations (two), and
splice-site mutations (two). Of the 12 mutations, each has only
been found in a single family, except for the p.Ala237Pro
mutations that have been detected in four families. For the 15
families with the 12 TSPAN12 mutations, ten had a family
history of FEVR, which suggests that this is an autosomal
dominant trait with incomplete penetrance, whereas the other
five families were isolated cases without a family history. The
approximately 6.1% (3/49) mutation frequency detected in
our  patients  is  comparable  to  the  10%  (7/70)  frequency
detected in one previous study [28]. The patients in that study
were determined to have no mutations in the other known
FEVR genes (NDP,FZD4, or LRP5) that might account for
approximately half of FEVR cases [30]. In another study, two
TSPAN12  mutations  were  present  in  5  of  11  probands
(45.5%), but these patients were previously excluded from
having mutations in NDP,FZD4 or LRP5. Four of the five
probands with the same mutation shared an at-risk haplotype
of at least 5.8 Mb, suggesting a founder effect [27].
For the patients with the previously reported TSPAN12
mutations, clinical phenotypes include the following: retinal
Figure 3. Fundus changes in the patient with the heterozygous c.313T>C mutation in Family B. A and B: These color photos demonstrate a
normal right posterior fundus and traction of the retinal vessels and macular degeneration in the left fundus. C and D: Fluorescein angiography
of the left eye shows straightening of the vessels with increasing branching (C) and a peripheral avascular zone (D). OD and OS represent the
right and left eyes, respectively.
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1131Figure 4. Fundus changes in the proband with the c.601delC mutation in Family C. A: Inferotemporal dragging of the optic disc and macula
is present in the right eye. B: Optical coherence tomography scan shows a flatter central macula in the right eye. C: Inferotemporal dragging
of the optic disc and macula is present in the left eye. OD and OS represent the right and left eyes, respectively.
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1132Figure 5. Fundus photos of the asymptomatic father with the c.601delC mutation and the unaffected mother without the mutation. A and B:
The mother has normal fundi. C-D: Fundus photos of the asymptomatic father shows normal posterior fundi. E and F: The father has increased
vessel branching in the equatorial area and a peripheral avascular zone. G and H: Optical coherence tomography scan shows normal macula
of the asymptomatic father.
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1133folds, temporal dragging of the optic disc and/or macula,
traction of the posterior retinal vessels, increased vascular
ramifications  in  the  equatorial  area,  a  peripheral  retinal
avascular zone, retinal pigmentary disturbances that mimic
retinitis  pigmentosa,  exudates,  and  retinal  detachments.
Retinal  folds  were  the  most  common  finding.  FEVR  in
asymptomatic individuals can be detected using fluorescein
angiography (Figure 5), but mild changes in the peripheral
retina may be neglected, which might partly contribute to the
nonpenetrance in a few families. Large phenotypic variations
have been observed between different individuals within a
family  and  between  different  eyes  in  individual  patients.
There  is  no  particular  genotype–phenotype  correlation
between particular mutations and certain clinical signs, which
suggests haploinsufficiency as the underlying mechanism that
induces the manifestation of the disease. Overall, the ocular
manifestations caused by TSPAN12 mutations are similar to
those due to mutations in FZD4, LRP5, or NDP [21,23,24].
The proteins encoded by TSPAN12, NDP, FZD4, and
LRP5 are important components of the Norrin/Fz4 signaling
pathway  (Norrin/Fz4/Lrp5/Tspan12  signaling  pathway),
which  controls  retinal  vascular  development  [16,19].
Recognizing additional mutations in these genes may not only
provide useful information for clinical diagnosis and genetic
counseling, but may also enrich our understanding of the
functional domains of these proteins. Mutations in these four
genes  all  lead  to  FEVR,  which  suggests  that  additional
components that participate in this signaling pathway may be
reasonable  candidates  in  those  FEVR  patients  without
mutations in these four genes.
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